# Diagnosis of Renal Cell Carcinoma on 68Ga-PSMA PET-CT and Radioligand Therapy With 177Lu-EB-PSMA-617

> **NCT05170555** · NA · UNKNOWN · sponsor: **Peking Union Medical College Hospital** · enrollment: 40 (estimated)

## Conditions studied

- Renal Cell Carcinoma

## Interventions

- **DRUG:** 68Ga-PSMA
- **DRUG:** 1.85GBq (50 mCi) of 177Lu-EB-PSMA-617

## Key facts

- **NCT ID:** NCT05170555
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-12-01
- **Primary completion:** 2022-10-01
- **Final completion:** 2023-07-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2021-12-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05170555

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05170555, "Diagnosis of Renal Cell Carcinoma on 68Ga-PSMA PET-CT and Radioligand Therapy With 177Lu-EB-PSMA-617". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05170555. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*